1. Home
  2. XXII vs KAVL Comparison

XXII vs KAVL Comparison

Compare XXII & KAVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XXII
  • KAVL
  • Stock Information
  • Founded
  • XXII 1998
  • KAVL 1998
  • Country
  • XXII United States
  • KAVL United States
  • Employees
  • XXII N/A
  • KAVL N/A
  • Industry
  • XXII Medicinal Chemicals and Botanical Products
  • KAVL Medicinal Chemicals and Botanical Products
  • Sector
  • XXII Health Care
  • KAVL Health Care
  • Exchange
  • XXII Nasdaq
  • KAVL Nasdaq
  • Market Cap
  • XXII 7.0M
  • KAVL 7.9M
  • IPO Year
  • XXII N/A
  • KAVL N/A
  • Fundamental
  • Price
  • XXII $8.09
  • KAVL $0.49
  • Analyst Decision
  • XXII
  • KAVL
  • Analyst Count
  • XXII 0
  • KAVL 0
  • Target Price
  • XXII N/A
  • KAVL N/A
  • AVG Volume (30 Days)
  • XXII 37.6K
  • KAVL 28.5K
  • Earning Date
  • XXII 08-12-2025
  • KAVL 06-10-2025
  • Dividend Yield
  • XXII N/A
  • KAVL N/A
  • EPS Growth
  • XXII N/A
  • KAVL N/A
  • EPS
  • XXII N/A
  • KAVL N/A
  • Revenue
  • XXII $23,869,000.00
  • KAVL $1,698,426.00
  • Revenue This Year
  • XXII $22.41
  • KAVL N/A
  • Revenue Next Year
  • XXII $76.35
  • KAVL N/A
  • P/E Ratio
  • XXII N/A
  • KAVL N/A
  • Revenue Growth
  • XXII N/A
  • KAVL N/A
  • 52 Week Low
  • XXII $6.28
  • KAVL $0.46
  • 52 Week High
  • XXII $2,837.04
  • KAVL $1.95
  • Technical
  • Relative Strength Index (RSI)
  • XXII 24.50
  • KAVL 36.05
  • Support Level
  • XXII $6.81
  • KAVL $0.52
  • Resistance Level
  • XXII $9.50
  • KAVL $0.56
  • Average True Range (ATR)
  • XXII 1.70
  • KAVL 0.03
  • MACD
  • XXII -0.32
  • KAVL -0.00
  • Stochastic Oscillator
  • XXII 20.46
  • KAVL 0.57

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

About KAVL Kaival Brands Innovations Group Inc.

Kaival Brands Innovations Group Inc is focused on growing and incubating innovative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.

Share on Social Networks: